Latest Shareholder Interests News

Savannah Goldfields has announced a $15 million placement to strengthen its balance sheet, repay debt, and fund a restart of gold production alongside an ambitious drilling program targeting resource extensions.

Invion Limited posted a $8.8 million loss for FY25, marking a 56.5% increase, while advancing clinical trials and securing fresh capital. The biotech faces a going concern warning amid ongoing development and funding challenges.

M3 Mining Limited has announced a significant leadership renewal alongside a strategic review aimed at streamlining operations, reducing costs, and focusing on high-value exploration assets.

Mach7 Technologies Limited reported a 16% revenue increase to AUD 33.8 million for FY25, alongside a 22% reduction in net loss, driven by a strategic shift to subscription-based sales and disciplined cost management.

Australian Finance Group Ltd (AFG) reported a 21% rise in statutory net profit after tax to $35 million for FY25, driven by record broker numbers and loan book growth. The company declared a fully franked final dividend of 5.3 cents per share, underscoring strong shareholder returns.

WCM Global Growth Limited reported a robust FY2025 with a 31% portfolio return and raised its fully franked final dividend, alongside an upgraded progressive dividend policy and a shareholder-friendly DRP discount.

WAM Active Limited reported a robust FY2025 with a 26.4% investment portfolio gain and a steady fully franked dividend of 6.0 cents per share, underscoring its active management approach amid evolving market conditions.

Australian Clinical Labs reported a 6.4% revenue increase and an 8.7% rise in underlying EBIT for FY25, maintaining disciplined growth and operational efficiency in a complex healthcare environment.

Whitebark Energy has exercised its option to acquire the remaining 30% stake in the Alinya project, gaining 100% ownership after independent assessments confirmed significant hydrocarbon, hydrogen, and helium resources.

Asset Vision Co Limited reported a 22.9% increase in revenue to $5.03 million for FY2025, alongside a widening net loss of $385,797. The company’s Annual Recurring Revenue surged 28%, supported by new contracts and product innovation.

Otto Energy has appointed industry veteran Chris Dorros as CEO, signaling a strategic push to leverage his two decades of upstream energy expertise. The move aligns with Otto’s growth ambitions and shareholder value focus.

Apiam Animal Health has entered a Process Deed granting Adamantem exclusivity to pursue a $0.88 per share acquisition proposal. The Independent Board Committee signals intent to recommend the deal, pending due diligence and shareholder approval.